Hyperhomocysteinemia in Patients on Antiepileptic Drugs - Relation to the Mutation of the MTHFR Gene
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023884%3A_____%2F01%3A00004845" target="_blank" >RIV/00023884:_____/01:00004845 - isvavai.cz</a>
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Hyperhomocysteinemia in Patients on Antiepileptic Drugs - Relation to the Mutation of the MTHFR Gene
Original language description
The causes of hyperhomocysteinemia are multifactorial and include both genetic and acquired components (deficiency of vitamins, drug interference). Treatment with some antiepileptic drugs - phenytoin, carbamazepine, primidone or phenobarbital, (hepatic microsomal enzyme inductors) or their combinations is associated with a risk of increased plasma total homocysteine concentrations and deficiencies in vitamins important for homocysteine remethylation., ,
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FP - Other medical fields
OECD FORD branch
—
Result continuities
Project
<a href="/en/project/NE5489" target="_blank" >NE5489: Differentiation of mild hyperhomocysteinemia, its diagnostic significance and possible use as the selective screening in population of children with risk for ca</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2001
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Clinical Chemistry and Laboratory Medicine
ISSN
—
e-ISSN
—
Volume of the periodical
39
Issue of the periodical within the volume
suppl.
Country of publishing house
DE - GERMANY
Number of pages
1
Pages from-to
"S341"
UT code for WoS article
—
EID of the result in the Scopus database
—